XML 82 R71.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 15, 2025
Feb. 14, 2025
Feb. 13, 2025
Nov. 07, 2024
Nov. 06, 2024
Jun. 24, 2024
Jan. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
May 06, 2025
Mar. 06, 2025
Mar. 05, 2025
Dec. 20, 2024
Subsidiary or Equity Method Investee [Line Items]                                    
Original principal amount               $ 141,948       $ 141,948   $ 144,495        
Net proceeds of June 2024 private placement equity offering with detachable warrants $ 610,000     $ 2,669,250               $ 2,194,745          
Deduction costs of offering 140,000     $ 330,750                            
Share price                               $ 0.10 $ 0.10  
Issuance of shares                   $ 2,529,449                
Issuance of stock, value                           $ 3,600,000        
Shares of common stock were exercised                                  
Net loss (income) attributable to noncontrolling interests               $ 58,525 $ (2,000,206)     $ 118,133 $ (1,939,143)          
Nobility Healthcare LLC [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Subsidiary ownership percentage               49.00%       49.00%            
Net loss (income) attributable to noncontrolling interests               $ (58,525) $ 2,000,206     $ (118,133) $ 1,939,143          
Nobility Healthcare LLC [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Equity method investment ownership percentage               51.00%       51.00%            
Officers [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Common stock issuance granted             27                      
Vesting drescription             Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates.                      
New Employees [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Common stock issuance granted             13                      
New Employees [Member] | Minimum [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Vesting period             1 year                      
New Employees [Member] | Maximum [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Vesting period             2 years                      
Employees [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Cancellation of restricted stock, shares                       0 1          
Private Placement [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Issuance of stock, shares           60                        
Share price           $ 5,020.00                        
Pre-funded unit price           $ 0.001                        
Common Stock [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Issuance of stock, shares                   311                
Share price                                   $ 1.00
Issuance of shares                   $ 1                
Common stock issuance granted                     40              
Cancellation of restricted stock, shares                 15   1              
Series B Warrants [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Warrants to purchase of common stock                             1,669,357      
Shares of common stock were exercised               1,897       1,897            
Shares of common stock were exercised, value               $ 3,793                    
Fair value of warrant derivative liability               $ 1,989,806       $ 1,989,806            
Prefunded Warrants [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Exercise price               $ 0.001       $ 0.001            
Shares of common stock were exercised               49,075       49,075            
Securities Purchase Agreement [Member] | Private Placement [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Net proceeds of June 2024 private placement equity offering with detachable warrants         $ 3,000,000.0                          
Issuance of stock, value         $ 3,600,000                          
Issuance of stock, shares         404                          
Securities Purchase Agreement [Member] | Common Stock [Member] | Private Placement [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Issuance of stock, shares         404                          
Securities Purchase Agreement [Member] | Senior Secured Convertible Notes [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Original principal amount $ 806,451                                  
Warrants to purchase of common stock 476,569                                  
Exercise price $ 2.124                                  
Original issue discount percentage 7.00%                                  
Gross proceeds $ 750,000                                  
Interest rate percentage 8.00%                                  
ELOC Purchase Agreement [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Committed equity financing facility $ 25,000,000                                  
Underwriting Agreement [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Net proceeds from offering   $ 13,480,000                                
Underwriting Agreement [Member] | Over-Allotment Option [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Issuance of shares   $ 14,308,300                                
Underwriting Agreement [Member] | Common Stock [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Offering percentage   15.00%                                
Underwriting Agreement [Member] | Common Stock [Member] | Over-Allotment Option [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Issuance of stock, shares   3,000                                
Underwriting Agreement [Member] | Series A Warrants [Member] | Over-Allotment Option [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Warrants to purchase of common stock   7,500                                
Underwriting Agreement [Member] | Series B Warrants [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Offering percentage   15.00%                                
Underwriting Agreement [Member] | Series B Warrants [Member] | Underwriting Discount [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Share price   $ 0.00001                                
Underwriting Agreement [Member] | Series B Warrants [Member] | Over-Allotment Option [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Warrants to purchase of common stock   7,500                                
Share price   $ 0.00001                                
Underwriting Agreement [Member] | Aegis Capital Corp [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Issuance of stock, shares     3,925                              
Share price     $ 300.00                              
Aggregate purchase price percentage   7.00%                                
Legal fees percentage   1.00%                                
Underwriting Agreement [Member] | Aegis Capital Corp [Member] | Series A Warrants [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Exercise price     375.00                              
Underwriting Agreement [Member] | Aegis Capital Corp [Member] | Series B Warrants [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Exercise price     600.00                              
Underwriting Agreement [Member] | Aegis Capital Corp [Member] | Prefunded Warrants [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Exercise price     $ 0.001                              
Issuance of stock, shares     46,075                              
Share price     $ 298.00                              
The Securities Purchase Agreement [Member]                                    
Subsidiary or Equity Method Investee [Line Items]                                    
Net proceeds of June 2024 private placement equity offering with detachable warrants           $ 2,900,000